Revance Therapeutics, Inc. earnings per share and revenue

RVNC earnings per share for the last quarter are -0.29 USD whereas the estimation was -0.36 USD which accounts for 19.95% surprise. Company revenue for the same period amounts to 65.39 M USD despite the estimated figure of 66.30 M USD. Estimated earnings per share for the next quarter are -0.27 USD, and revenue is expected to reach 68.17 M USD. Also watch annual changes over time to get a bigger picture of RVNC earnings per share and revenue dynamics.